Clinical Trials Update provides you with latest news about clinical trials conducted by MVA member companies. The update gives insight to progress in studies, results and possible indications. As an MVA member please feel free to send us press releases for Clinical Trials Update at akn@mva.org.

Week 31

Genmab and GSK Announce Positive Top-Line Results in Ofatumumab Pivotal Study

31 Juli - Genmab and GlaxoSmithKline have announced positive top-line results from an interim analysis of the Phase 3 pivotal study evaluating ofatumumab to treat two groups of chronic lymphocytic leukemia patients with high unmet medical need. At the interim analysis, the study met the primary endpoint in both populations and the results from the secondary endpoints also support the primary endpoint.

Read more

Back